4価インフルエンザワクチンと23価肺炎球菌ワクチンの同時投与による免疫原性

基本情報

NCT ID: NCT02592486
ステータス: 完了
試験のフェーズ: 第4相
試験タイプ: 介入
目標被験者数: 162
治験依頼者名: Kameda Medical Center

概要

The immunogenicity of simultaneous administration of quadrivalent influenza vaccine and pneumococcal vaccine was unknown. The purpose of present study is to compare the immunogenicity of simultaneous administration of influenza vaccine and pneumococcal vaccine with that of separate administration.

対象疾患

Pneumococcal PneumoniaInfluenza

介入

Simultaneous administration of Pneumovax NP® and Fluvic HA syringe®(BIOLOGICAL)

Sequential administration of Pneumovax NP® and Fluvic HA syringe®(BIOLOGICAL)

依頼者（Sponsor）

Kameda Medical Center(OTHER)

Ppd Development, Lp(INDUSTRY)

MSD株式会社(INDUSTRY)

Osaka University(OTHER)

実施施設 (1)

医療法人鉄蕉会　亀田総合病院

Kamogawa, Chiba, Japan